Global clinical trial equipment and ancillary solutions

Dublin, December 1, 2021 (GLOBE NEWSWIRE) – The “Clinical Trial Equipment and Ancillary Solutions Market Size, Share and Trend Analysis Report by Product (Procurement, Procurement / Logistics), by Phase (Phase I, II, III), By Region (APAC, North America) and Segment Forecast, 2021-2028 “has been added to ResearchAndMarkets.com offer.

The global market size for clinical trial equipment and ancillary solutions is expected to reach $ 4.4 billion by 2028, according to the publisher’s new report, with a CAGR of 8.2% during the period forecast. The growing pharmaceutical and medical sectors, the globalization of clinical trials and increasing R&D spending are the factors driving the market.

The procedure for clinical trials has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve large numbers of patients and patient subgroups, as well as many countries and research sites. As a result, the number of challenges supply chain managers face when working with clinical trial equipment and auxiliaries has increased. The rental of medical equipment alleviates the burden of storage, retrieval and disposal. Another important reason for making the decision is that equipment rental reduces the large upfront expense and significant investment required to provide accredited clinical trial sites.

The COVID-19 pandemic has affected the global market, resulting in a slowdown in the supply chain for equipment and ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments that were going on before the pandemic have been halted, while many new trials have been launched in the search for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitalization of healthcare and the adoption of advanced technologies and techniques.

Highlights of Clinical Trial Equipment and Ancillary Solutions Market Report

• The procurement / logistics products segment dominated the market with a revenue share of over 38% in 2020 due to the high number of clinical trials globally resulting in increased demand for efficient logistics services.
• The phase III segment accounted for the maximum revenue share of the global market in 2020. Phase III studies are the most effective approach to discover a new standard of treatment
• North America dominated the global market in 2020 and is expected to remain dominant even in the forecast years due to an increase in the number of CROs and pharmaceutical and medical companies in the region.
• Asia-Pacific is expected to be the fastest growing regional market during the forecast period as it becomes an increasingly important site for clinical trial investigations

Main topics covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary
2.1 Market outlook
2.2 Segment Outlook

Chapter 3 Clinical Trial Equipment and Ancillary Solutions Market: Variables, Trends and Scope
3.1 Market Lineage Outlook
3.1.1 Parents’ Market Outlook
3.1.2 Auxiliary Market Outlook
3.2 Mapping of penetration and growth prospects
3.3 Market dynamics
3.3.1 Market Drivers Analysis
3.3.1.1 Evolution of clinical trial needs
3.3.1.2 Increase in R&D investments
3.3.1.3 Growing pharmaceutical and medical device industry
3.3.2 Analysis of market restrictions
3.3.2.1 Increasing cost of clinical trials
3.4 Porter’s five forces analysis
3.5 PESTEL analysis
3.6 Analysis of major transactions and strategic alliances
3.7 COVID impact analysis
3.8 Clinical Trial Equipment and Ancillary Solutions Market: Total Addressable Market (TAM) Analysis

Chapter 4 Clinical Trial Equipment and Ancillary Solutions Market: Product Segment Analysis
4.1 Clinical Trial Equipment and Ancillary Solutions: Market Share Analysis, 2020 and 2028
4.2 Procurement
4.2.1 Supply Market, 2016-2028 (USD Million)
4.2.2 Procurement
4.2.2.1 Public procurement market, 2016 – 2028 (USD million)
4.2.2.2 Equipment
4.2.2.2.1 Equipment Market, 2016-2028 (USD Million)
4.2.2.2.2 Auxiliaries
4.2.2.2.2.1 Accessories market, 2016 – 2028 (USD million)
4.2.3 Rental
4.2.3.1 Rental market, 2016 – 2028 (USD million)
4.2.3.2 Equipment
4.2.3.2.1 Equipment Market, 2016-2028 (USD Million)
4.2.3.3 Auxiliaries
4.2.3.3.1 Accessories market, 2016 – 2028 (USD million)
4.3 Procurement / Logistics
4.3.1 Supply / Logistics Market, 2016-2028 (USD Million)
4.3.2 Transport
4.3.2.1 Transportation Market, 2016-2028 (USD Million)
4.3.3 Packaging
4.3.3.1 Packaging Market, 2016-2028 (USD Million)
4.3.4 Others
4.3.4.1 Other markets, 2016 – 2028 (USD million)
4.4 Services
4.4.1 Services Market, 2016-2028 (USD Million)
4.4.2 Calibration
4.4.2.1 Calibration Market, 2016-2028 (USD Million)
4.4.3 Equipment maintenance
4.4.3.1 Equipment Maintenance Market, 2016-2028 (USD Million)
4.4.4 Others
4.4.4.1 Other markets, 2016 – 2028 (USD million)
4.5 Others
4.5.1 Others Market, 2016-2028 (USD Million)

Chapter 5 Clinical Trial Equipment and Ancillary Solutions Market: Phase Segment Analysis
5.1 Clinical Trial Equipment and Ancillary Solutions: Market Share Analysis, 2020 and 2028
5.2 Phase I
5.2.1 Phase I Market, 2016-2028 (USD Million)
5.3 Phase II
5.3.1 Phase II Market, 2016-2028 (USD Million)
5.4 Phase III
5.4.1 Phase III Market, 2016-2028 (USD Million)
5.5 Phase IV
5.5.1 Phase IV Market, 2016-2028 (USD Million)

Chapter 6 Clinical Trial Equipment and Ancillary Solutions Market: Regional Analysis

Chapter 7 Company Profiles
7.1 Company profiles
7.1.1 Auxiliary LP
7.1.1.1 Company overview
7.1.1.2 Benchmarking of services
7.1.1.3 Strategic initiatives
7.1.2 Imperial CRS
7.1.2.1 Company overview
7.1.2.2 Benchmarking of services
7.1.3 Woodley Equipment Company Ltd
7.1.3.1 Company overview
7.1.3.2 Benchmarking of services
7.1.3.3 Strategic initiatives
7.1.4 Thermo Fisher Scientific Inc.
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 PPD, Inc
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Société Internationale Parexel
7.1.6.1 Company overview
7.1.6.2 Product Benchmarking
7.1.6.3 Strategic initiatives
7.1.7 MediCapital Rent
7.1.7.1 Company overview
7.1.7.2 Product benchmarking
7.1.8 SAS equipment
7.1.8.1 Company overview
7.1.8.2 Product benchmarking
7.1.9 MRI
7.1.9.1 Company overview
7.1.9.2 Product Benchmarking
7.1.10 MARKING A UPS BUSINESS
7.1.10.1 Company overview
7.1.10.2 Product Benchmarking
7.1.10.3 Strategic initiatives
7.1.11 MYONEX
7.1.11.1 Company overview
7.1.11.2 Product Benchmarking
7.1.12 Your path
7.1.12.1 Company overview
7.1.12.2 Product Benchmarking
7.1.12.3 Strategic initiatives

For more information on this report, visit https://www.researchandmarkets.com/r/15uix